EFILA

LONGRUNN MEDICAL TECHNOLOGIES owns a patented ingredient, EFILA which is derived from a unique microbial strain extracted from Korean Pine Tree Mushrooms. This microbial strain then undergoes a precise fermentation process using a technology was awarded an Invention Patent for the manufacturing method of Ceriporia Lacerata culture broth extracts and pharmaceutical composition for prevention and treatment of Diabetic Disease and diabetic complications. 

Another competitive advantage we have is our fully integrated system, encompassing scientific research, raw material manufacturing, product manufacturing, to final packaging. This ensures quality measures are met at every stage.